Resverlogix Corp. (RVX : TSX)
Common Stock
$0.10
CAD
+0.01 (5.56%)
Last updated: 2026-06-22
RVX
Resverlogix Corp.
WealthAwesomePerformance
1 Day
+5.56%
1 Week
+0.00%
1 Month
+0.00%
YTD
-5.00%
Key Statistics
Market Cap
$30.11M
52W High
$0.30
52W Low
$0.04
P/E Ratio
-
50 Day MA
$0.10
200 Day MA
$0.11
Beta
1.04
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/22/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 2,100 |
| 6/19/2026 | $0.10 | $0.10 | $0.09 | $0.09 | $0.09 | 11,500 |
| 6/18/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 4,000 |
| 6/17/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 39,000 |
| 6/16/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 65,052 |
| 6/15/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 1,300 |
| 6/12/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 0 |
| 6/11/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 0 |
| 6/8/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 13,000 |
| 6/5/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 1,989 |
Analyst Price Targets
Based on analyst covering RVX
Wall Street analysts forecast RVX stock price to rise 8005.3% over the next 12 months.
Consensus
No RatingAvg. Target
C$7.70
+8005.3% Upside
Current Price
C$0.10
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RVX's historical volatility
30-Day Vol
62.9%
Annualized
90-Day Vol
87.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.09 | C$0.07 โ C$0.11 |
| 60 trading days | C$0.08 | C$0.06 โ C$0.11 |
| 90 trading days | C$0.08 | C$0.05 โ C$0.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Resverlogix Corp.
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID-19 conditions. The company has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-4.55M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -0.04
- Book Value
- -0.39
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About RVX
Articles Featuring RVX.TO
Latest articles and analysis covering RVX.TO
Why Resverlogix Corp. stock is plummeting today
Resverlogix Corp. (RVX.TO) saw its stock plummet by 10% today, closing at CA$0.09. The drop raises concerns about the company's financial stability and its ability to meet obligations.
Why Resverlogix Corp. stock is skyrocketing today
Resverlogix Corp. (RVX.TO) experienced a notable 5.26% increase in its stock price, closing at CA$0.10. This rise may be attributed to recent financial developments that have sparked investor optimism.
Why Resverlogix Corp. stock is skyrocketing today
Resverlogix Corp. stock soared by 5.26% yesterday, closing at CA$0.10, fueled by strategic financial moves and a potential turnaround in investor sentiment.
Why Resverlogix Corp. stock is plummeting today
Resverlogix Corp. faced a challenging trading day, with its stock price falling by 5%. Investors are left wondering about the company's financial stability amidst a backdrop of limited positive news.
Why Resverlogix Corp. stock is skyrocketing today
Resverlogix Corp. (RVX.TO) closed up 5.26% in the latest trading session, reaching CA$0.10. This increase may be linked to recent financial activities that have sparked investor interest.
Why Resverlogix Corp. stock is skyrocketing today
Resverlogix Corp. is seeing a significant rise in its stock price, attributed to recent corporate actions that may indicate a positive outlook for the company. Investors should stay informed about ongoing developments.
Why Resverlogix Corp. stock is skyrocketing today
Resverlogix Corp. shares rose by 5.26% in the latest trading session, driven by renewed investor interest amid recent corporate developments. The company's market cap is CA$30 million, highlighting its position in the biotech space.
What to Watch for in Resverlogix Corp.'s (RVX.TO) Upcoming Earnings Report
Resverlogix Corp. is set to report earnings on May 14, 2026, but with no EPS estimates available, investors are left speculating on the company's performance.
